MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
50 hedge funds and large institutions have $91M invested in Merrimack Pharmaceuticals, Inc. in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 7 closing their positions.
Holders
50
Holders Change
+3
Holders Change %
+6.38%
% of All Funds
0.8%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
10
Increased
14
Reduced
9
Closed
7
Calls
$6.79M
Puts
$3.96M
Net Calls
+$2.84M
Net Calls Change
-$20K
Top Buyers
1 |
MAP
1
Madison Avenue Partners
New York
|
$6.8M |
2 |
2
Invesco
Atlanta,
Georgia
|
$2.59M |
3 |
WSL
3
Western Standard LLC
Los Angeles,
California
|
$20.6M |
4 |
NM
4
Newtyn Management
New York
|
$23M |
5 |
![]()
5
Marshall Wace
London,
United Kingdom
|
$1.21M |